SAN DIEGO--The industrial genomics and bioinformatics company Sequenom announced last week that it had filed with the Securities and Exchange Commission for a public offering of common stock. The offering was led by Warburg Dillon Read, with assistance from Robertson Stephens and SG Cowen. The underwriters will be granted a 30-day over-allotment option to purchase additional shares of common stock from the company.
Sequenom's MassArray system combines proprietary enzymology and bioinformatics in a miniaturized chip-based format with mass spectrometry.
Proceeds of the offering will be used to hire additional sales and support personnel, expand its facilities, continue to develop and manufacture existing products, research and develop additional products, and to prosecute patents. Funds could also be used to acquire products, technologies, or companies, and to repay long-term debt and accrued interest of approximately $4.2 million, the company said.